Application Nr Approved Date Route Status External Links
NDA204569 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Belsomra ® (Suvorexant) Is Indicated For The Treatment Of Insomnia Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance. Belsomra Is An Orexin Receptor Antagonist Indicated For The Treatment Of Insomnia, Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Suvorexant SUVOREXANT ZINC49036447

Comments